View in EDS HTML Full Text PDF Full Text

Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.

Saved in:
Bibliographic Details
Title: Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.
Authors: Gogas H; National and Kapodistrian University of Athens, Athens, Greece. helgogas@gmail.com., Ravimohan S; Bristol Myers Squibb, Princeton, NJ, USA., Datta A; Bristol Myers Squibb, Princeton, NJ, USA., Chhibber A; Bristol Myers Squibb, Princeton, NJ, USA., Couselo EM; Vall d'Hebron Barcelona Hospital and Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain., Diab A; MD Anderson Cancer Center, Houston, TX, USA., Pereira C; Fundação Pio XII - Hospital de Câncer de Barretos, São Paulo, Brazil., Quéreux G; Unité Cancéro-Dermatologie, Nantes, France., Sandhu S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Curti B; Eerle A. Chiles Research Institute, Providence Cancer Institute of Oregon, Portland, OR, USA., Khushalani NI; Moffitt Cancer Center, Tampa, FL, USA., Taylor MH; Eerle A. Chiles Research Institute, Providence Cancer Institute of Oregon, Portland, OR, USA., Daniels GA; Moores UCSD Cancer Center, La Jolla, CA, USA., Spreafico A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Meniawy T; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia., Van Den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Sun Y; Bristol Myers Squibb, Princeton, NJ, USA., Arriaga Y; Bristol Myers Squibb, Princeton, NJ, USA., Zhou M; Bristol Myers Squibb, Princeton, NJ, USA., Long GV; The Melanoma Institute Australia, The University of Sydney and Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Lebbé C; Université Paris Cité, Dermato-Oncology and CIC AP-HP Hôpital Saint Louis, Cancer Institute APHP, Nord-Université Paris Cité, Paris, France.; INSERM U976 HIPI, Paris, France.
Source: NPJ precision oncology [NPJ Precis Oncol] 2024 Jul 19; Vol. 8 (1), pp. 150. Date of Electronic Publication: 2024 Jul 19.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39025948
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gogas+H%22">Gogas H</searchLink>; National and Kapodistrian University of Athens, Athens, Greece. helgogas@gmail.com.<br /><searchLink fieldCode="AU" term="%22Ravimohan+S%22">Ravimohan S</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Datta+A%22">Datta A</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Chhibber+A%22">Chhibber A</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Couselo+EM%22">Couselo EM</searchLink>; Vall d'Hebron Barcelona Hospital and Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Diab+A%22">Diab A</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Pereira+C%22">Pereira C</searchLink>; Fundação Pio XII - Hospital de Câncer de Barretos, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Quéreux+G%22">Quéreux G</searchLink>; Unité Cancéro-Dermatologie, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Sandhu+S%22">Sandhu S</searchLink>; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Curti+B%22">Curti B</searchLink>; Eerle A. Chiles Research Institute, Providence Cancer Institute of Oregon, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Khushalani+NI%22">Khushalani NI</searchLink>; Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Taylor+MH%22">Taylor MH</searchLink>; Eerle A. Chiles Research Institute, Providence Cancer Institute of Oregon, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Daniels+GA%22">Daniels GA</searchLink>; Moores UCSD Cancer Center, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Spreafico+A%22">Spreafico A</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Meniawy+T%22">Meniawy T</searchLink>; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia.<br /><searchLink fieldCode="AU" term="%22Van+Den+Eertwegh+AJM%22">Van Den Eertwegh AJM</searchLink>; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Sun+Y%22">Sun Y</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Arriaga+Y%22">Arriaga Y</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+M%22">Zhou M</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Long+GV%22">Long GV</searchLink>; The Melanoma Institute Australia, The University of Sydney and Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Lebbé+C%22">Lebbé C</searchLink>; Université Paris Cité, Dermato-Oncology and CIC AP-HP Hôpital Saint Louis, Cancer Institute APHP, Nord-Université Paris Cité, Paris, France.; INSERM U976 HIPI, Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2024 Jul 19; Vol. 8 (1), pp. 150. <i>Date of Electronic Publication: </i>2024 Jul 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39025948
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41698-024-00641-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 150
    Titles:
      – TitleFull: Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gogas H
      – PersonEntity:
          Name:
            NameFull: Ravimohan S
      – PersonEntity:
          Name:
            NameFull: Datta A
      – PersonEntity:
          Name:
            NameFull: Chhibber A
      – PersonEntity:
          Name:
            NameFull: Couselo EM
      – PersonEntity:
          Name:
            NameFull: Diab A
      – PersonEntity:
          Name:
            NameFull: Pereira C
      – PersonEntity:
          Name:
            NameFull: Quéreux G
      – PersonEntity:
          Name:
            NameFull: Sandhu S
      – PersonEntity:
          Name:
            NameFull: Curti B
      – PersonEntity:
          Name:
            NameFull: Khushalani NI
      – PersonEntity:
          Name:
            NameFull: Taylor MH
      – PersonEntity:
          Name:
            NameFull: Daniels GA
      – PersonEntity:
          Name:
            NameFull: Spreafico A
      – PersonEntity:
          Name:
            NameFull: Meniawy T
      – PersonEntity:
          Name:
            NameFull: Van Den Eertwegh AJM
      – PersonEntity:
          Name:
            NameFull: Sun Y
      – PersonEntity:
          Name:
            NameFull: Arriaga Y
      – PersonEntity:
          Name:
            NameFull: Zhou M
      – PersonEntity:
          Name:
            NameFull: Long GV
      – PersonEntity:
          Name:
            NameFull: Lebbé C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 07
              Text: 2024 Jul 19
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2397-768X
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ precision oncology
              Type: main
ResultId 1